- Poster presentation
- Open Access
Interactions of nebulized heparin with intravenous antithrombin for combined therapy of acute lung injury
© Rehberg et al. 2011
- Published: 1 March 2011
- Acute Lung Injury
- Post Injury
- Total Body Surface Area
- Inhalation Injury
- Smoke Inhalation Injury
The present randomized, controlled, experimental study was performed to compare the effects of two different doses of nebulized heparin on the efficiency of the combined therapy with intravenous (i.v.) recombinant human antithrombin (rhAT) and nebulized tissue plasminogen activator (TPA) in an established ovine model of acute lung injury.
Chronically instrumented sheep were subjected to a 40% total body surface area third-degree burn and 48 breaths of cotton smoke under deep anesthesia. Sheep were randomly assigned to receive an i.v. infusion of 6 U/kg/hour rhAT (started 1 hour post injury) combined with nebulized TPA (2 mg every 4 hour, started 4 hours post injury) and heparin (5,000 (low-dose) or 10,000 IU (high-dose), respectively, every 4 hours, started 2 hours post injury) or 0.9% NaCl i.v. and aerosolized (control; n = 6 each). All sheep were awake, mechanically ventilated and fluid resuscitated according to international guidelines for 48 hours. Data are expressed as mean ± SEM at 48 hours.
Both strategies attenuated lung injury, as suggested by higher PaO2/FiO2 ratios (low-dose: 276 ± 44 mmHg, high-dose: 352 ± 25 mmHg, control: 134 ± 30 mmHg) and lower airway peak pressures (27 ± 2 cmH2O, 27 ± 1 cmH2O, 36 ± 2 cmH2O). Notably, the combination with low-dose heparin reduced pulmonary transvascular fluid flux (16 ± 2 ml/hour, 40 ± 5 ml/hour, 51 ± 4 ml/hour) and the permeability index (9 ± 1 ml/hour, 19 ± 2 ml/hour, 25 ml/hour) and increased plasma protein (4.6 ± 0.1 g/dl, 3.9 ± 0.2 g/dl, 4.0 ± 0.3 g/dl) versus both other groups (P < 0.05 each). Cumulative net fluid balance was lower in the low-dose heparin group (2.1 ± 0.2l) versus control animals (3.5 ± 0.4 l; P < 0.05).
With the lower dose of heparin the systemic anti-inflammatory effects of i.v. rhAT on vascular leakage are more pronounced, while the local, beneficial effects of nebulized heparin on gas exchange are preserved. Therefore, lower doses of heparin may be more beneficial when used in combination with i.v. rhAT for the treatment of combined burn and smoke inhalation injury. A reduction of the systemic interaction between heparin and rhAT represents a possible explanation.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.